Equillium, Inc. (EQ) vs VAXART, INC. (VXRT)
- Equillium, Inc. EQ 1.34 −4.29%
- VAXART, INC. VXRT 0.37 −7.50%
Equillium, Inc. and VAXART, INC. are both Biotechnology companies. Equillium, Inc. and VAXART, INC. are of similar size ($92.4M and $88.8M). Equillium, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. grew revenue faster over the last twelve months: 22.3% against 13.9%. VAXART, INC. has the higher net margin (16.0% vs 0.00%) and the higher return on invested capital (2,542.3% vs 0.00%). Across the 15 metrics below, VAXART, INC. leads on 14 and Equillium, Inc. on 1.
Valuation
Profitability
| Metric | EQ | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 16.63% | 0.00% |
| Net margin | 0.00% | 16.02% | 0.00% |
| Free cash flow margin | 0.00% | 17.64% | 0.00% |
| Return on equity | (58.98%) | 62.42% | (50.12%) |
| Return on assets | (50.68%) | 16.26% | (45.60%) |
| Return on invested capital | 0.00% | 2,542.26% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack